We are live on ! Find out more
PAVMZ

PAVmed Inc. Series Z Warrant
PAVMZ

Delisted

PAVMZ was delisted on the 30th of April, 2025.

Back to rankings

4 hedge funds and large institutions have $1.87K invested in PAVmed Inc. Series Z Warrant in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more capital invested

Capital invested by funds: $1.1K → $1.87K (+$773)

33% more funds holding

Funds holding: 3 → 4 (+1)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.75K
2
Citadel Advisors
Citadel Advisors
Florida
+$4

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$15
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$1.37K +$2.75K +138,195 New
Citadel Advisors
2
Citadel Advisors
Florida
$425 +$4 +200 +0.5%
UBS Group
3
UBS Group
Switzerland
$77 -$15 -749 -9%
Bank of America
4
Bank of America
North Carolina
$1 – – –

PAVMZ Hedge Fund Activity: Q4 2024 in Review

4 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q4 2024, worth a combined $1.87K — up 70% from $1.1K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new PAVMZ positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $2.75K. The largest seller was UBS Group, cutting an estimated $15.

  • 4 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q4 2024, up from 3 in Q3 2024.
  • Funds reported $1.87K of PAVmed Inc. Series Z Warrant stock for Q4 2024, up 70% quarter-over-quarter.
  • 1 fund opened new PAVmed Inc. Series Z Warrant positions in Q4 2024 and 0 closed out, a net change of +1 holder.
  • The largest PAVmed Inc. Series Z Warrant buyer in Q4 2024 was Susquehanna International Group, an estimated $2.75K added.
  • The largest PAVmed Inc. Series Z Warrant seller in Q4 2024 was UBS Group, an estimated $15 sold.

Based on aggregated 13F filings for Q4 2024.